Symbols

SGP

SpyGlass Pharma·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SGP

Spyglass Pharma, Inc.

Industry

Biological Technology

Established Date

01/07/2019

Listing Date

02/06/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.spyglasspharma.com

Security Type

Common stock

Office address

27061 Aliso Creek Rd. Suite 100 Aliso Viejo California 92656

Business

Introduction

SpyGlass Pharma, Inc., was incorporated on January 7, 2019 under the laws of the State of Delaware. The company, a late-stage biopharmaceutical company, is initiating Phase 3 clinical trials of its lead product, an IOL-mounted, controlled-release, drug delivery system designed to treat glaucoma through delivery of the drug bimatoprost. Its mission is to significantly improve the lives of patients with chronic eye diseases by developing durable drug delivery solutions that give patients and surgeons confidence in long-term disease control and vision protection.